![]() APIM Therapeutics APIM Therapeutics is a clinical-stage biotech company focusing on the development of treatments in the fields of oncology and inflammation. | ||
Founding Date | Founding Date 2010 | Founding Date 1999 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Trondheim, NO HQ Rissa, NO | Locations Mechelen, BE HQ Romainville, FR Leiden, NL Basel, CH Waltham, US |
Employees | Employees 7 | Employees 70437% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €1.1b (FY, 2025) |
Cost of goods | Cost of goods kr1.2m (FY, 2021) | Cost of goods €25.7m (FY, 2025) |
Gross profit | Gross profit (kr1.2m) (FY, 2021) | Gross profit €1.2b (FY, 2025) |
Net income | Net income (kr14.8m) (FY, 2021) | Net income €320.9m (FY, 2025) |